Discontinue using terbinafine tablets if these reactions occur. Advise patients to report to their physician if any of the following symptoms occur: hives, mouth sores, blistering and peeling of skin, ...

Please provide your email address to receive an email when new articles are posted on . Treatment efficacy was achieved by 76.67% of the continuous regimen group vs. 26.67% of the pulsed group (P = ...

The FDA today approved the first generic versions of Novartis’ Lamisil (terbinafine hydrochloride) tablets, used to treat nail fungus infection (onychomycosis). The agency approved applications from ...

A study published in the Journal of Drugs in Dermatology compared the clinical cure rates associated with continuous- versus pulse-dose terbinafine regimens for toenail onychomycosis. Sixty patients ...